NCT01683955View on ClinicalTrials.gov

Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty

PHASE1CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

November 3, 2013

Study Completion Date

November 3, 2013

Conditions
Acute Blood Loss AnemiaOsteoarthritis, Hip
Interventions
DRUG

Tranexamic acid

Topical tranexamic acid (2g/100mL 0.9% saline)

DRUG

Placebo

100mL 0.9% sterile saline

Trial Locations (2)

48067

Henry Ford Hospital, Detroit

48202

HFH Main campus, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT01683955 - Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter